| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Combined brain and spinal FDG PET in the differentiation between ALS and ALS mimics – correction and additional validation study
|
Van Weehaeghe, Donatienne
|
|
|
52 |
1 |
p. 109-112
|
artikel
|
| 2 |
Construction and preclinical evaluation of a 124I-labelled bispecific antibody targeting PD-L1 and PD-L2
|
Yao, Yuan
|
|
|
52 |
1 |
p. 36-47
|
artikel
|
| 3 |
Correction to: EANM’24 Abstract Book Congress Oct 19–23, 2024
|
Csismazia, Andrea
|
|
|
52 |
1 |
p. 374
|
artikel
|
| 4 |
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
|
Giunta, Emilio Francesco
|
|
|
52 |
1 |
p. 326-334
|
artikel
|
| 5 |
Deep learning-aided respiratory motion compensation in PET/CT: addressing motion induced resolution loss, attenuation correction artifacts and PET-CT misalignment
|
Lu, Yihuan
|
|
|
52 |
1 |
p. 62-73
|
artikel
|
| 6 |
Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [68Ga]Ga-/[18F]F-PSMA-11/-1007, [68Ga]Ga-FAPI-46 and 2-[18F]FDG PET/CT: a pilot study
|
Pabst, Kim M.
|
|
|
52 |
1 |
p. 342-353
|
artikel
|
| 7 |
Development of [177Lu]Lu-LNC1010 for peptide receptor radionuclide therapy of nasopharyngeal carcinoma
|
Chen, Jianhao
|
|
|
52 |
1 |
p. 247-259
|
artikel
|
| 8 |
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2
|
Wang, Jinling
|
|
|
52 |
1 |
p. 9-21
|
artikel
|
| 9 |
Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemia
|
Gäble, Alexander
|
|
|
52 |
1 |
p. 366-367
|
artikel
|
| 10 |
EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders
|
Nanni, Cristina
|
|
|
52 |
1 |
p. 171-192
|
artikel
|
| 11 |
Efficacy and safety of rechallenge with [177Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer
|
Santo, Giulia
|
|
|
52 |
1 |
p. 354-365
|
artikel
|
| 12 |
Egesta Lopci, Luigi Mansi (editors). Advanced imaging and therapy in neuro-oncology, 1st edition. Springer, 2024. ISBN: 978-3-031-59340-6
|
Morbelli, Silvia
|
|
|
52 |
1 |
p. 1-2
|
artikel
|
| 13 |
Enhanced detection of damaged myocardium and risk stratification in hypertrophic cardiomyopathy using integrated [68Ga]Ga-FAPI-04 PET/CMR imaging
|
Ding, Jie
|
|
|
52 |
1 |
p. 98-108
|
artikel
|
| 14 |
Exploring the value of FAP-targeted PET/CT in differentiating breast cancer molecular subtypes: a preliminary study
|
Liu, Tianxin
|
|
|
52 |
1 |
p. 280-290
|
artikel
|
| 15 |
[18F]AlF-CBP imaging of type I collagen for non-invasive monitoring of pulmonary fibrosis in preclinical models
|
Liu, Yang
|
|
|
52 |
1 |
p. 22-35
|
artikel
|
| 16 |
Feasibility and therapeutic potential of [177Lu]Lu-FAPI-2286 in patients with advanced metastatic sarcoma
|
Banihashemian, Seyedeh Somayyeh
|
|
|
52 |
1 |
p. 237-246
|
artikel
|
| 17 |
Fetal dose minimization: ultra-low dose long axial field of view (LAFOV) PET/CT imaging of a pregnant patient
|
van Snick, J. H.
|
|
|
52 |
1 |
p. 370-371
|
artikel
|
| 18 |
Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis
|
Willemse, Jeroen R. J.
|
|
|
52 |
1 |
p. 225-236
|
artikel
|
| 19 |
Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancer
|
Rupp, Niels J.
|
|
|
52 |
1 |
p. 305-313
|
artikel
|
| 20 |
Internal auditory canal tumor presented on [18F]AlF-FAPI-74 and [18F]AlF-PSMA-BCH PET/CT in a prostate cancer patient
|
Cheng, Xin
|
|
|
52 |
1 |
p. 372-373
|
artikel
|
| 21 |
Loss of synaptic density in nucleus basalis of meynert indicates distinct neurodegeneration in Alzheimer’s disease: the RJNB-D study
|
Li, Binyin
|
|
|
52 |
1 |
p. 134-144
|
artikel
|
| 22 |
[177Lu]Lu DOTATOC PRRT with PARP inhibitors in small cell lung cancer
|
Piscopo, Leandra
|
|
|
52 |
1 |
p. 260-262
|
artikel
|
| 23 |
May the Nuclear Medicine be with you! Neuroendocrine tumours and the return of nuclear medicine
|
Ekmekcioglu, Ozgul
|
|
|
52 |
1 |
p. 3-8
|
artikel
|
| 24 |
[99mTc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients
|
Tingen, Hendrea Sanne Aletta
|
|
|
52 |
1 |
p. 88-97
|
artikel
|
| 25 |
Non-invasive diagnosis of liver fibrosis via MRI using targeted gadolinium-based nanoparticles
|
Wu, Shiman
|
|
|
52 |
1 |
p. 48-61
|
artikel
|
| 26 |
Noninvasive quantification of [18F]SynVesT-1 binding using simplified reference tissue model 2
|
Naganawa, Mika
|
|
|
52 |
1 |
p. 113-121
|
artikel
|
| 27 |
Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication
|
Kirienko, Margarita
|
|
|
52 |
1 |
p. 208-224
|
artikel
|
| 28 |
PET imaging of synaptic vesicle glycoprotein 2 subtype A for neurological recovery in ischemic stroke
|
Luo, Xiaoyun
|
|
|
52 |
1 |
p. 158-170
|
artikel
|
| 29 |
Preclinical evaluation of the novel [18F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease
|
Zajicek, Franziska
|
|
|
52 |
1 |
p. 122-133
|
artikel
|
| 30 |
Pulmonary embolism as an incidental finding in [15O]H2O PET/CT myocardial perfusion imaging
|
Nagel, Julie Loft
|
|
|
52 |
1 |
p. 368-369
|
artikel
|
| 31 |
Spatial and temporal tracking of multi-layered cells sheet using reporter gene imaging with human sodium iodide symporter: a preclinical study using a rat model of myocardial infarction
|
Otani, Kentaro
|
|
|
52 |
1 |
p. 74-87
|
artikel
|
| 32 |
Spatial-temporal dynamic evolution of lewy body dementia by metabolic PET imaging
|
Niu, Jiaqi
|
|
|
52 |
1 |
p. 145-157
|
artikel
|
| 33 |
Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β
|
De Groof, Timo W.M.
|
|
|
52 |
1 |
p. 193-207
|
artikel
|
| 34 |
Standardized template for clinical reporting of PSMA PET/CT scans
|
Esfahani, Shadi A.
|
|
|
52 |
1 |
p. 335-341
|
artikel
|
| 35 |
The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis
|
Soeterik, Timo F. W.
|
|
|
52 |
1 |
p. 314-325
|
artikel
|
| 36 |
The impact of PET imaging on triple negative breast cancer: an updated evidence-based perspective
|
Filippi, Luca
|
|
|
52 |
1 |
p. 263-279
|
artikel
|
| 37 |
The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE
|
Maccauro, Marco
|
|
|
52 |
1 |
p. 291-304
|
artikel
|
Tijdschrift beschrijving